Skip NavigationSkip to Content

Rapid Emergence of T Follicular Helper and Germinal Center B Cells Following Antiretroviral Therapy in Advanced HIV Disease

  1. Author:
    Wong, Chun-Shu
    Buckner, Clarisa M
    Lage, Silvia Lucena
    Pei, Luxin
    Assis, Felipe L
    Dahlstrom, Eric W
    Anzick, Sarah L
    Virtaneva, Kimmo
    Rupert,Adam
    Davis, Jeremy L
    Zhou, Ting
    Laidlaw, Elizabeth
    Manion, Maura
    Galindo, Frances
    Anderson, Megan
    Seamon, Catherine A
    Sneller, Michael C
    Lisco, Andrea
    Deleage,Claire
    Pittaluga, Stefania
    Moir, Susan
    Sereti, Irini
  2. Author Address

    Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States., Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, MT, United States., Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Intramural Clinical Management and Operations Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States., Critical Care Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, MD, United States., AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.,
    1. Year: 2021
    2. Epub Date: 2021 12 01
  1. Journal: Frontiers in immunology
    1. 12
    2. Pages: 752782
  2. Type of Article: Article
  3. Article Number: 752782
  4. ISSN: 1664-3224
  1. Abstract:

    Low nadir CD4 T-cell counts in HIV+ patients are associated with high morbidity and mortality and lasting immune dysfunction, even after antiretroviral therapy (ART). The early events of immune recovery of T cells and B cells in severely lymphopenic HIV+ patients have not been fully characterized. In a cohort of lymphopenic (CD4 T-cell count < 100/µL) HIV+ patients, we studied mononuclear cells isolated from peripheral blood (PB) and lymph nodes (LN) pre-ART (n = 40) and 6-8 weeks post-ART (n = 30) with evaluation of cellular immunophenotypes; histology on LN sections; functionality of circulating T follicular helper (cTfh) cells; transcriptional and B-cell receptor profile on unfractionated LN and PB samples; and plasma biomarker measurements. A group of 19 healthy controls (HC, n = 19) was used as a comparator. T-cell and B-cell lymphopenia was present in PB pre-ART in HIV+ patients. CD4:CD8 and CD4 T- and B-cell PB subsets partly normalized compared to HC post-ART as viral load decreased. Strikingly in LN, ART led to a rapid decrease in interferon signaling pathways and an increase in Tfh, germinal center and IgD-CD27- B cells, consistent with histological findings of post-ART follicular hyperplasia. However, there was evidence of cTfh cells with decreased helper capacity and of limited B-cell receptor diversification post-ART. In conclusion, we found early signs of immune reconstitution, evidenced by a surge in LN germinal center cells, albeit limited in functionality, in HIV+ patients who initiate ART late in disease. Copyright © 2021 Wong, Buckner, Lage, Pei, Assis, Dahlstrom, Anzick, Virtaneva, Rupert, Davis, Zhou, Laidlaw, Manion, Galindo, Anderson, Seamon, Sneller, Lisco, Deleage, Pittaluga, Moir and Sereti.

    See More

External Sources

  1. DOI: 10.3389/fimmu.2021.752782
  2. PMID: 34938286
  3. PMCID: PMC8686113
  4. WOS: 000731696000001

Library Notes

  1. Fiscal Year: FY2021-2022
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel